thiazolidines has been researched along with Insulin Resistance in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (15.79) | 18.2507 |
| 2000's | 1 (5.26) | 29.6817 |
| 2010's | 13 (68.42) | 24.3611 |
| 2020's | 2 (10.53) | 2.80 |
| Authors | Studies |
|---|---|
| Nie, G; Peng, W; Rao, D; Shi, Y; Wu, J; Xia, Q; Zhang, M | 1 |
| Li, Y; Liu, S; Nie, Y; Sun, K; Wang, H; Wang, X; Zhou, Y | 1 |
| Ahn, JH; Bae, GH; Jeong, HG; Jung, WH; Kang, NS; Kang, SK; Kim, HY; Kim, KY; Park, JS; Park, SB; Rhee, SD | 1 |
| Holland, WL; Sifuentes, A; Tao, C | 1 |
| Koriyama, H; Kurinami, H; Morishita, R; Moritani, T; Nakagami, H; Pang, Z; Shimamura, M; Shimosato, T; Tenma, A | 1 |
| Bansal, P; Chamallamudi, MR; Gowdra, VS; Manohara Reddy, SA; Mudgal, J; Nampurath, GK; Nayak, PG; Shenoy, GG; Valiathan, M | 1 |
| Nakamura, S; Nakazato, M; Sakoda, H; Tsubouchi, C; Tsuchimochi, W; Ueno, H; Yamashita, E | 1 |
| Kusunoki, M; Miyata, T; Nakamura, T; Natsume, Y; Oshida, Y; Sato, D; Tsutsui, H; Tsutsumi, K | 1 |
| Ahn, CW; Cho, YW; Chung, CH; Han, KA; Hong, S; Jang, HC; Ku, BJ; Lee, CB; Lee, MK; Moon, MK; Park, CY; Park, SW; Son, HS | 1 |
| Kutoh, E; Terayama, S; Wada, A | 1 |
| Choe, SS; Choi, EB; Chung, H; Jeong, HW; Kim, HS; Kim, JB; Kim, KH; Kim, WS; Lee, GY; Lee, H; Lee, HK; Lee, JH; Lee, JW; Park, HS; Park, KS; Park, SB; Ro, S; Shin, D; Shin, HJ | 1 |
| Schwanstecher, C; Schwanstecher, M | 1 |
| Okazaki, R | 1 |
| Ogawa, D; Shikata, K | 1 |
| Chaudhary, S; Dube, A; Kothari, V; Sachan, N; Upasani, CD | 1 |
| Gross, B; Staels, B | 1 |
| Hirayama, R; Niigata, K; Noshiro, O; Shikama, H; Shimaya, A; Yoneta, T | 1 |
| Ohta, M | 1 |
| Ide, T; Mochizuki, T; Murakami, K; Ohashi, M; Tsunoda, M | 1 |
6 review(s) available for thiazolidines and Insulin Resistance
| Article | Year |
|---|---|
Regulation of glucose and lipid homeostasis by adiponectin: effects on hepatocytes, pancreatic β cells and adipocytes.
Topics: Adipocytes; Adiponectin; Adipose Tissue; Animals; Apoptosis; Cell Proliferation; Ceramides; Down-Regulation; Fatty Liver; Glucose; Hepatocytes; Humans; Insulin Resistance; Insulin-Secreting Cells; Lipid Metabolism; Liver; Lysophospholipids; Mice; Sphingosine; Thiazolidines | 2014 |
Targeting type 2 diabetes.
Topics: Adipose Tissue; Caloric Restriction; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Glucagon-Like Peptide 1; Glucose; Homeostasis; Humans; Hypoglycemic Agents; Inflammation; Insulin Resistance; Insulin-Secreting Cells; Metformin; Signal Transduction; Thiazolidines | 2011 |
[Diabetes Mellitus and bone metabolism].
Topics: Bone and Bones; Diabetes Complications; Diabetes Mellitus; Diphosphonates; Fractures, Bone; Glycation End Products, Advanced; Humans; Hyperglycemia; Hypoglycemic Agents; Insulin; Insulin Resistance; Osteoporosis; Risk; Thiazolidines | 2011 |
[Microinflammation in diabetic nephropathy].
Topics: Animals; Diabetic Nephropathies; Drug Design; Glucagon-Like Peptide 1; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation; Insulin Resistance; Metabolic Syndrome; Mice; Molecular Targeted Therapy; PPAR gamma; Rats; Thiazolidines | 2011 |
PPAR agonists: multimodal drugs for the treatment of type-2 diabetes.
Topics: Animals; Blood Glucose; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Homeostasis; Humans; Insulin; Insulin Resistance; Lipid Metabolism; Lipoproteins; Peroxisome Proliferator-Activated Receptors; PPAR alpha; PPAR delta; PPAR gamma; Thiazolidines | 2007 |
[Current advances in the treatment of diabetes mellitus].
Topics: Aldehyde Reductase; Arteriosclerosis; Blood Glucose; Diabetes Mellitus; Enzyme Inhibitors; Guanidines; Humans; Hypoglycemic Agents; Insulin Resistance; Rhodanine; Thiazolidines | 1999 |
2 trial(s) available for thiazolidines and Insulin Resistance
| Article | Year |
|---|---|
DPP-4 Inhibitor Teneligliptin Improves Insulin Resistance and Serum Lipid Profile in Japanese Patients with Type 2 Diabetes.
Topics: Aged; Asian People; Blood Glucose; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Female; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin Resistance; Lipids; Male; Middle Aged; Prospective Studies; Pyrazoles; Thiazolidines; Treatment Outcome | 2015 |
Efficacy and safety of teneligliptin, a novel dipeptidyl peptidase-4 inhibitor, in Korean patients with type 2 diabetes mellitus: a 24-week multicentre, randomized, double-blind, placebo-controlled phase III trial.
Topics: Administration, Oral; Blood Glucose; Combined Modality Therapy; Diabetes Mellitus, Type 2; Diet, Diabetic; Dipeptidyl-Peptidase IV Inhibitors; Double-Blind Method; Exercise; Glycated Hemoglobin; Humans; Hyperglycemia; Hypoglycemia; Incidence; Insulin Resistance; Patient Compliance; Pyrazoles; Republic of Korea; Thiazolidines; Time Factors | 2016 |
11 other study(ies) available for thiazolidines and Insulin Resistance
| Article | Year |
|---|---|
Teneligliptin prevents doxorubicin-induced inflammation and apoptosis in H9c2 cells.
Topics: Animals; Antineoplastic Agents; Apoptosis; Blood Glucose; Cell Line; Cell Survival; Chemokine CCL2; Dipeptidyl Peptidase 4; Doxorubicin; Glucagon-Like Peptide 1; Humans; Inflammation; Insulin Resistance; Interleukin-1beta; Myocytes, Cardiac; Oxidative Stress; Pyrazoles; Rats; Reactive Oxygen Species; Receptors, KIR3DL1; Thiazolidines | 2020 |
NLRP3 inflammasome inhibitor CY-09 reduces hepatic steatosis in experimental NAFLD mice.
Topics: Animals; Body Weight; Diet, High-Fat; Disease Models, Animal; Insulin Resistance; Male; Mice, Inbred C57BL; Non-alcoholic Fatty Liver Disease; Thiazolidines; Thiones; Triglycerides | 2021 |
Anti-diabetic and anti-inflammatory effect of a novel selective 11β-HSD1 inhibitor in the diet-induced obese mice.
Topics: 11-beta-Hydroxysteroid Dehydrogenase Type 1; 3T3-L1 Cells; Adipocytes; Animals; Anti-Inflammatory Agents; Cortisone; Diet; Gene Expression Regulation; Glucose Tolerance Test; Humans; Hypoglycemic Agents; Hypothalamus; Insulin Resistance; Liver; Male; Mice; Mice, Obese; Models, Molecular; Obesity; Pituitary-Adrenal System; Protein Conformation; Thiazolidines | 2013 |
The dipeptidyl peptidase-4 inhibitor teneligliptin improved endothelial dysfunction and insulin resistance in the SHR/NDmcr-cp rat model of metabolic syndrome.
Topics: Aging; Animals; Dipeptidyl-Peptidase IV Inhibitors; Disease Models, Animal; Endothelium, Vascular; Glucose; Insulin Resistance; Metabolic Syndrome; Pyrazoles; Rats; Rats, Inbred SHR; Thiazolidines | 2014 |
Synthesis, characterization, and preclinical evaluation of new thiazolidin-4-ones substituted with p-chlorophenoxy acetic acid and clofibric acid against insulin resistance and metabolic disorder.
Topics: 2,4-Dichlorophenoxyacetic Acid; Animals; Antioxidants; Blood Glucose; Clofibric Acid; Glucose Metabolism Disorders; Humans; Insulin; Insulin Resistance; Leptin; Liver; Mice; Rats; Thiazolidines | 2014 |
Teneligliptin improves glycemic control with the reduction of postprandial insulin requirement in Japanese diabetic patients.
Topics: Aged; Blood Glucose; Combined Modality Therapy; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Drug Therapy, Combination; Female; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Humans; Hyperglycemia; Hypoglycemia; Hypoglycemic Agents; Insulin; Insulin Resistance; Japan; Middle Aged; Monitoring, Ambulatory; Postprandial Period; Pyrazoles; Thiazolidines | 2015 |
Teneligliptin, a Chemotype Prolyl-Thiazolidine-Based Novel Dipeptidyl Peptidase-4 Inhibitor with Insulin Sensitizing Properties.
Topics: Adult; Aged; Blood Glucose; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Female; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin; Insulin Resistance; Male; Middle Aged; Prospective Studies; Pyrazoles; Sitagliptin Phosphate; Thiazolidines | 2016 |
A newly identified CG301269 improves lipid and glucose metabolism without body weight gain through activation of peroxisome proliferator-activated receptor alpha and gamma.
Topics: Analysis of Variance; Animals; Body Weight; Carbohydrate Metabolism; Cell Line; Computer Simulation; Diabetes Mellitus, Type 2; Glucose; Glucose Tolerance Test; Humans; Insulin Resistance; Lipid Metabolism; Liver; Mice; Myocardial Reperfusion Injury; Oxazoles; PPAR alpha; PPAR gamma; Rats; Reverse Transcriptase Polymerase Chain Reaction; Thiazolidines; Transfection | 2011 |
NS-1: a novel partial peroxisome proliferator-activated receptor γ agonist to improve insulin sensitivity and metabolic profile.
Topics: Adipocytes; Adipogenesis; Animals; Body Weight; Glucose Tolerance Test; Insulin Resistance; Male; Metabolome; Mice; Mice, Inbred C57BL; NIH 3T3 Cells; Pioglitazone; PPAR gamma; Thiazolidinediones; Thiazolidines | 2012 |
Insulin sensitizer YM268 ameliorates insulin resistance by normalizing the decreased content of GLUT4 in adipose tissue of obese Zucker rats.
Topics: Adipose Tissue; Animals; Blood Glucose; Glucose Transporter Type 4; Hypoglycemic Agents; Insulin; Insulin Resistance; Male; Monosaccharide Transport Proteins; Muscle Proteins; Rats; Rats, Zucker; Thiazoles; Thiazolidines | 1997 |
Amelioration by KRP-297, a new thiazolidinedione, of impaired glucose uptake in skeletal muscle from obese insulin-resistant animals.
Topics: Animals; Blood Glucose; Glucose; Hypoglycemic Agents; Insulin Resistance; Male; Mice; Mice, Inbred C57BL; Muscle, Skeletal; Obesity; Thiazoles; Thiazolidines | 1999 |